Zevra Therapeutics Inc (STU:1GDA)
€ 9.8 +0.080 (+0.82%) Market Cap: 588.53 Mil Enterprise Value: 397.88 Mil PE Ratio: 12.43 PB Ratio: 3.12 GF Score: 69/100

Q1 2026 Zevra Therapeutics Inc Earnings Call Transcript

May 06, 2026 / 08:30PM GMT
Release Date Price: €9.54 (+5.76%)
Operator

Good afternoon and thank you for joining Zevra's first quarter 2026 financial results and corporate update conference call. Today's call is being recorded and will be available via the Investor Relations section of the company's website later today. The host for today's call is Nichol Ochsner, Zevra's Vice President of Investor Relations and Corporate Communications.

Nichol Ochsner
Zevra Therapeutics Inc - Vice President, Investor Relations and Corporate Communications

Thank you and welcome to those who are joining us. Today, we will provide an overview of our recent accomplishments, followed by review of our first quarter 2026 financial results. I encourage you to read our financial results news release, which was distributed this afternoon and is available in the Investor section of our website.

Before we begin the call, please note that certain information shared today will include forward-looking statements. Actual results may differ materially from those stated or implied in any forward-looking statements due to risks and uncertainties associated

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot